REGN vs STE · P/E 14, rev $14.34B vs P/E 25, rev $5.46B
Regeneron Pharmaceuticals Inc (REGN) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the REGN and STE stock pages for the full models.
Not investment advice.